Capricor Therapeutics reported a GAAP loss of $7.818 million for the 3 months of 2022, up 51.7% from $5.152 million in the prior year. The company did not generate revenue. A year earlier the figure was $40,816 thousand.
Capricor Therapeutics reported a GAAP loss of $7.818 million for the 3 months of 2022, up 51.7% from $5.152 million in the prior year. The company did not generate revenue. A year earlier the figure was $40,816 thousand. 
English (US) 